Active Filter(s):
Details:
GeoVax will use its MVA-VLP vaccine platform and expertise to design and construct the vaccine candidate and BravoVax will provide further development including testing and manufacturing support.
Lead Product(s): 2019-nCoV vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Vaccine
Partner/Sponsor/Collaborator: GeoVax
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration January 28, 2020